학술논문

Treatmentwith glucagon-like peptide-1 receptor agonists and incidence of dementia: Data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers.
Document Type
Article
Source
Alzheimer's & Dementia: Translational Research & Clinical Interventions; 2022, Vol. 8 Issue 1, p1-9, 9p
Subject
GLUCAGON-like peptide-1 receptor
GLUCAGON-like peptide-1 agonists
REPORTING of diseases
TYPE 2 diabetes diagnosis
ALZHEIMER'S disease
Language
ISSN
23528737
Abstract
Copyright of Alzheimer's & Dementia: Translational Research & Clinical Interventions is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)